These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

705 related items for PubMed ID: 16613672

  • 21. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [Abstract] [Full Text] [Related]

  • 22. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK, Joe YA, Lee SK, Kim EK, O E, Kim HK, Oh BJ, Hong SH, Hong YK.
    Cancer Lett; 2010 Feb 28; 288(2):251-60. PubMed ID: 19664879
    [Abstract] [Full Text] [Related]

  • 23. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ.
    Clin Cancer Res; 2005 Mar 01; 11(5):1999-2007. PubMed ID: 15756026
    [Abstract] [Full Text] [Related]

  • 24. [Effect of vascular endothelial growth factor antisense oligodeoxynucleotides on angiogenesis in lymphoma of nude mice].
    Tong YJ, Zhang M, Zou P, Guo R, Yuan YH.
    Ai Zheng; 2005 Jan 01; 24(1):62-6. PubMed ID: 15642202
    [Abstract] [Full Text] [Related]

  • 25. [Effects of nonsteroidal anti-inflammatory drug celecoxib on expression of cyclooxygenase-2 (COX-2) in ovarian carcinoma cell].
    Wang HJ, Liu XJ, Yang KX, Luo FM, Lou JY, Peng ZL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep 01; 37(5):757-60. PubMed ID: 17037745
    [Abstract] [Full Text] [Related]

  • 26. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M.
    Oncol Rep; 2007 Oct 01; 18(4):801-9. PubMed ID: 17786339
    [Abstract] [Full Text] [Related]

  • 27. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL.
    Cancer Res; 2002 Feb 01; 62(3):625-31. PubMed ID: 11830509
    [Abstract] [Full Text] [Related]

  • 28. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
    Qin J, Yuan J, Li L, Liu H, Qin R, Qin W, Chen B, Wang H, Wu K.
    Biomed Pharmacother; 2009 Mar 01; 63(3):241-8. PubMed ID: 18617357
    [Abstract] [Full Text] [Related]

  • 29. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
    Eibl G, Takata Y, Boros LG, Liu J, Okada Y, Reber HA, Hines OJ.
    Cancer Res; 2005 Feb 01; 65(3):982-90. PubMed ID: 15705899
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.
    Lee A, Frischer J, Serur A, Huang J, Bae JO, Kornfield ZN, Eljuga L, Shawber CJ, Feirt N, Mansukhani M, Stempak D, Baruchel S, Glade Bender J, Kandel JJ, Yamashiro DJ.
    Cancer Res; 2006 Apr 15; 66(8):4378-84. PubMed ID: 16618763
    [Abstract] [Full Text] [Related]

  • 31. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
    Hata K, Nakayama K, Fujiwaki R, Katabuchi H, Okamura H, Miyazaki K.
    Gynecol Oncol; 2004 Apr 15; 93(1):215-22. PubMed ID: 15047239
    [Abstract] [Full Text] [Related]

  • 32. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T, Watanabe M, Hasegawa H, Nishibori H, Ishii Y, Tatematsu H, Yamamoto K, Kubota T, Kitajima M.
    Anticancer Res; 2003 Apr 15; 23(1A):245-9. PubMed ID: 12680220
    [Abstract] [Full Text] [Related]

  • 33. [Effects of celecoxib on PGE2 synthesis and COX-2 and VEGF-C mRNA expression in Tca8113 cell lines].
    Li WZ, Wang XY, Ding YQ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar 15; 29(3):466-8. PubMed ID: 19304526
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Effects of hydroxy safflor yellow A on blood vessel and mRNA expression with VEGF and bFGF of transplantation tumor with gastric adenocarcinoma cell line BGC-823 in nude mice].
    Xi S, Zhang Q, Xie H, Liu L, Liu C, Gao X, Zhang J, Wu L, Qian L, Deng X.
    Zhongguo Zhong Yao Za Zhi; 2009 Mar 15; 34(5):605-10. PubMed ID: 19526794
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.
    Zhao QT, Yue SQ, Cui Z, Wang Q, Cui X, Zhai HH, Zhang LH, Dou KF.
    Life Sci; 2007 Jan 09; 80(5):484-92. PubMed ID: 17097688
    [Abstract] [Full Text] [Related]

  • 38. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells.
    Basu GD, Liang WS, Stephan DA, Wegener LT, Conley CR, Pockaj BA, Mukherjee P.
    Breast Cancer Res; 2006 Jan 09; 8(6):R69. PubMed ID: 17156488
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Inhibitive effects of mifepristone on growth of breast cancer: experiment with animal model].
    Tian XS, Zhou WH, Wu GJ, Sun JZ, Cong MH.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 26; 88(8):559-63. PubMed ID: 18649774
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.